Kilitch Drugs (India) Ltd.
Snapshot View

View in App

Prices View details >>

140.90 +0.30 ▲0.2%

31 March 2023, 04:01:00 PM
Volume: 3,531

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kilitch.com
Market Cap 217.45 Cr.
Enterprise Value(EV) 221.90 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.28 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 22.44 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 93.99 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.50 Calculated using Price: 140.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.56 Cr. 15,582,319 Shares
FaceValue 10
Company Profile
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.21%
1 Week
-7.49%
1 Month
-2.32%
3 Month
-9.68%
6 Month
-15.27%
1 Year
-15.98%
2 Year
+73.84%
5 Year
+77.34%
10 Year
+587.32%

Ratios View Details >>

9 years 2012-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 78.03 -0.25 -9.91 -8.59 4.95 3.36 0.71 3.09 4.73
Return on Capital Employed (%) 76.95 -0.74 -10.11 -8.69 6.08 7.59 1.95 4.40 7.26
Return on Assets (%) 46.26 -0.19 -9.25 -7.86 4.36 2.85 0.59 2.19 3.03

Balance Sheet View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 115 120 109 101 112 121 118 127 139 145
Non Curr. Liab. 1 -1 -1 -2 -2 -1 -1 -1 -1 -1
Curr. Liab. 60 7 8 12 15 20 22 73 69 64
Minority Int. 1 1 2 2 2 1 0
Equity & Liab. 177 126 116 110 126 143 142 202 208 208
Non Curr. Assets 10 79 68 62 63 78 86 122 94 104
Curr. Assets 167 47 47 49 63 65 56 80 114 104
Misc. Exp. not W/O 0 0
Total Assets 177 126 116 110 126 143 142 202 208 208

Profit Loss View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 108 19 21 29 51 82 53 69 114 131
Other Income 1 3 3 1 3 5 5 3 3 2
Total Income 109 22 24 30 54 88 58 71 117 133
Total Expenditure -95 -21 -25 -29 -46 -76 -53 -63 -104 -114
PBIDT 14 1 -2 1 9 11 5 8 13 19
Interest -3 0 0 0 0 -1 -1 -1 -1 -4
Depreciation -5 -2 -10 -10 -2 -2 -2 -2 -2 -4
Taxation -21 1 0 0 -1 -5 -1 -1 -3 -3
Exceptional Items 92
PAT 76 0 -11 -9 5 4 1 4 6 8
Minority Interest 1 0 1 2
Share Associate
Other Related Items
Consolidated Net Profit 77 0 -11 -9 5 4 1 4 7 10
Adjusted EPS 58 0 -8 -7 4 2 1 2 5 6

Cash Flow View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 22 -29 -8 17 1 1 0 4 46 6
Cash Fr. Inv. -24 41 -31 -20 -2 -4 -14 -10 -38 -15
Cash Fr. Finan. 7 -9 0 0 0 6 17 1 2 7
Net Change 6 2 -39 -2 0 2 3 -5 10 -2
Cash & Cash Eqvt 9 12 5 3 2 5 8 3 13 10

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 68.63 68.63 68.33 68.33 68.25 68.25 68.25 68.25 68.25
Public 31.37 31.37 31.67 31.67 31.75 31.75 31.75 31.75 31.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 29 Mar 2023
Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time read with Code of Prohibition of Insider Trading of the Company the Trading Windows for dealing in Securities of the Company will remain closed for all the Designated Persons of the Company and their immediate relatives with effect from Saturday 1st April 2023 till the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March 2023
Mon, 20 Mar 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 (Listing Regulations) please find enclosed herewith the copy of Newspaper Publication published on Sunday 19th March 2023 in the Free Press Journal - English Edition and Nava Shakti - Marathi Edition pertaining to Notice of Extraordinary General Meeting and e-voting details.
Sat, 18 Mar 2023
Notice Of Extraordinary General Meeting To Be Held On Tuesday 11Th April 2023
We would like to inform you that Extraordinary General Meeting (EGM) of the Company will be held on Tuesday 11th April 2023 at 9:00 am (IST) through Video Conferencing or Other Audio Visual Means.

Technical Scans View Details >>

Fri, 31 Mar 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Close Below Last Week Low Close Below Last Week Low
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Kilitch Drugs (India) Ltd.

What is Kilitch Drugs(India) share price?
Can I buy Kilitch Drugs(India) shares now?
What is the Market Cap of Kilitch Drugs(India)?
What are the key metrics to analyse Kilitch Drugs(India)?
What is the 52 Week High and Low of Kilitch Drugs(India)?
What is the trend of Kilitch Drugs(India) share price?